Recipharm equips a further three facilities for US serialisation
Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped three more of its facilities with serialisation capabilities in...
Fresenius Medical Care achieves improved health outcomes and savings in Demonstration Program in the United States
Fresenius Medical Care, the world’s largest provider of dialysis products and services, announced the results from the first performance year...
Intercept Pharmaceuticals Appoints Christian Weyer as Executive Vice President of Research & Development
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral...
Corbus Pharmaceuticals Expands Intellectual Property Portfolio with Patent Issuance Covering the Use of Anabasum for the Treatment of Rare Fibrotic Diseases
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious...
Teva Announces New Organization Structure and Leadership Changes
Teva Pharmaceutical Industries Ltd announced a new organization and leadership structure aimed to achieve better commercial focus and drive value...
AstraZeneca and Chinese Future Industry Investment Fund establish joint venture to develop new medicines in China
AstraZeneca announced a strategic joint venture with the Chinese Future Industry Investment Fund (FIIF) to form an equally-owned, stand-alone company...
Novartis’ Ultibro® Breezhaler® significantly improved COPD patients’ lung function after direct switch from Seretide®
Novartis announced positive results from the FLASH study examining the safety and efficacy of directly switching chronic obstructive pulmonary disease...
GSK Submits Landmark IMPACT Data To US Regulatory Authority To Support Expanded Label For Trelegy Ellipta
GlaxoSmithKline plc and Innoviva, Inc. announced the filing of a supplemental New Drug Application (sNDA) with the US Food and...
Exelixis to present phase 3 CELESTIAL trial results of cabozantinib at ASCO-GI Symposium
Exelixis has announced that the phase 3 CELESTIAL trial results have been accepted as a late-breaking presentation at the 2018...
Systech International And NKP Pharma Expand Presence In India
Systech International, a global technology leader in serialization, product safety, and consumer and brand protection, and NKP Pharma, an innovator...
Latest News
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.